Given the scale of the current situation which globally is now much worse than feared and the need for mass POC testing, there is less doubt in my mind than ever for a massive ramp up of production of our test to ensure the safe working of our population and that those who test positive can be isolated or given the right treatments. The numbers of tests required will be in the hundreds of millions per month. As soon as our test is in manufacturing and validated the need for more partnerships is going to be huge to match the potential demand.
The other key Developement which Avacta need is the acceleration of the virus blocking technology. It is one thing to detect and isolate individuals but the need to block the virus and treat patients is going to be key to getting our planet back to safety.
The company remains best places to be a key solution to multiple aspects of helping remove the risk of Covid19.
The next huge project will be the targeted chemotherapy which given the effects on people’s treatment programs for cancer through the last 6 months is going to be even more important.
Bring this together and you have a hugely valuable business.
Well, all those who think information from charts don’t work, I have increased my holding by 150,000 shares through the ups and downs of the share price. This share has performed beautifully so far.
Not saying any more on this subject. I must have just been very lucky....erm...
ISO accreditation is about quality standard proceedings being in place, to ensure the quality of a product. It is not, to be clear a standard for testing validation to be applied to a product. ISO numbers are applied to quality procedures within businesses.
You will note BBI have a ISO quality standard (13485) in place relevant to application of CE marking and regulation approval processes critical to accelerating all required approvals which the LFD Avacta Test.
Very good partner for Avacta.
I first invested here in March 2017, first buy was just over 5p. I still have a nice holding, but I had sold down back in April / May from a ever growing holding till that point.
Bushveld Minerals have continued to deliver on promises and predictions based on their own information given to the market and the foresight of many astute investors here. The latest piece of the jigsaw is to take over control at Enerox the key part of Cellcube. One of. The worlds most advanced VRFB manufactures. Timing as always has been key for Fortune Mojapelo and his team. SA have now commenced the BESS project in SA and I have every reason to think that BMN will take a large chunk of these tenders.
Fortune and his management have tried to ensure they are protecting the work force during these challenging Covid19 times. The market in China is clearly ahead on the vanadium requirement and Bushveld have been quick to change there supply profile towards China where prices are growing. But, we are on the brink of a large step up for the global vanadium market, through an increase in infrastructure both in terms of construction and energy. Today’s prices are starting to grow and BMN’s operation costs remain ultra low. The resource under their control remains one of the biggest on the planet and with any spike in prices the income jump would be huge and accelerate Bushvelds market position. Sure we are in uncertain times, but buying in to Bushveld at these levels is unlikely to Be possible for long. In the days ahead any entry to the investment at 10 to 14p is looking like a very good point now. We are close to another quarterly update and potentially good numbers which may just catch the market off guard. Is a repeat of a strong rise possible as the autumn of 2018? I would not say it is certain, but it is possible. Those BESS contracts will be like a 100 dollar a kilo vanadium price equivalent from my understanding of the amount of vanadium required.
The opportunity in front of investors here is a strong one indeed. For the savvy ones here, it could be exactly the 260% plus rise towards 50p coming soon.
Time to add in the days ahead!
I wish everyone every success. You might see (or hear) from me a little more in the weeks ahead. I have been watching and reading and looking for signs. There are small green shoots and trees could becoming!
GAZALA69, in my many meetings this week in the small talk, I had very similar discussions. In fact most people have very little understanding of how a test works or what is involved. They are all hoping for a vaccine. But asked would you be happy to be one of the first to have it, there is a universal NO Thanks! Then what about a test with results in less than 10 minutes, potentially less than 5 minutes using a small amount of saliva. Most think that would be the answer to removing the need for PPE masks and shields. But in the work place the question that business leaders have is what will the cost be?
So the point is, short term production cost and development costs will require a strong price, however as time goes on and more and more LFD manufacturers take up the production partnerships opportunities with Avacta and sales become truly global the price will drop dramatically, but revenue due to numbers will continue to grow.
The next point most say, that knowing me, I must have an investment interest! Then the introduction to Avacta and it’s multiple revenue opportunities as well as the potential targeted chemotherapy solutions going for phase 1 clinical testing in the next 6 months and interest is immediate.
Alltorque, of course I am a ‘nice guy’! I am invested here and BMN heavily. I have multiple business projects going on currently and my time is much more limited.
I tell you that I am delighted with the progress Alastair Smith is making here and keeping investors up to speed as developments are unfolded. His positivity in the directors talk interview was very clear. The POC laterial flow test looks like it s going to be as good if not better than expected. I truly expect strong market appreciation once the test goes on sale for several years here.
With respect to BMN I am still invested and I have made clear I sold 80% of my holding at a crucial time to invest in Covid19 stocks, however, Avacta came to my attention because of the potential chemotherapy treatment and that potential remains the biggest long term gain for Avacta. I happen to think now is a truly incredible time to add to Bushveld Minerals, they have a huge story and making good on every potential. They have a massive potential to grow quickly, they have a broker target 6 times higher than the current SP and they are hugely profit making. But, AIM doesn’t like them. But a great time to buy both in my opinion.
Run out of time!
Well CaptinStainley, my thought is BAMS production and results may well be the next RNS. I expect this within the next few days! I think it really is due.
This was always going to be the first to market. At is is though I sincerely believe there will not be much time between the release of both testing systems.
I have to say, I don't think today the market has understood fully the implication of todays news, the SP although had a usual instant spike but only small, then recovered to where is was, and then in the final moments are bunch of MM decided to drop the SP into the close. Maybe tomorrow morning we will see another quick recovery!
Something is going to happen soon we are not about to start production of millions of LFD POC tests per week and not think they are going to be possibly the very best test on the market and not expect to see a huge take up on immediate delivery orders as well as forward orders. That might be our £4 to £5 day?
Not gone anywhere PL75. Just a very busy man!
Delighted with today’s RNS. Just another step towards real value and progress towards the worlds two most important testing systems for Covid19.
My investment and my belief in the opportunity and potential for Avacta remains more than intact. The journey is progressing very well.
For me, the position we now find the company in, is that we have two tests effectively ready for market, validation and optimisation are in progress or virtually completed. The progress now is with finalising the right manufactures and production capacities with the right costs. They may even be ahead of this. But, if both the BAMS and POC LFT are as good and simple as they should be. Then when they announce to the world global orders should come flying in and the quantities will be vast. So I expect the business to be getting everything ready before making the huge announcement to the market.
I am extremely confident that we will see two very significant announcements very soon. They will be a catalyst to a rapid growth of opportunities for Avacta in the world of diagnostics. But more importantly they will help accelerate the growth of the business in the therapeutics business which will get a very significant global opportunity and publicity.
Viruses and cancer are not going away and Avacta has the ability to make a huge difference and contribution to the fight and Affimer technology will be a major success.
In the meantime small percentage buys and sells at strategic opportunities are helping my portfolio of Avacta shares grow day by day.
But one of theses days Avacta will put out an RNS during the day and we will rocket!
I am keeping the faith and patience will be rewarded.
Have a good day all! I agree with Ophidian a blue day!
Mortgagefreeman, thanks for asking, I have gone nowhere. I am awaiting the next news which will be the BAMS update, then new partnerships and then the big one the LFD RNS.
I have multiple business projects which are taking all my time. I am keeping a broad view of progress and the current situation and making the most of opportunities.
The current drop was inevitable given no news but I would not be surprised to see this blue before the day is out. BAMS is due very soon and could come at anytime. When it does expect a very decent jump into the £2 plus holding point. By the end of August, I would be surprised if we are not close the £4. Sales through September may see another spike. But, one step at a time.
My holding now exceeds 750k shares and that is a very good hold for me. My portfolio building is now quietly on some new projects which I expect to make strong gains in the future.
Avacta is a long term hold for me and I expect to hold for 2 to 3 years minimum or until a buyout if that happens.
Anyway cheers all and let’s hope for a strong afternoon!
Finally the government are seeing sense and easing of restrictions is being halted. The situation is on a knife edge. They need the economy operational and want people to have a holiday, but it is like a path straight back to disaster and a huge spike. If people don’t take precautions seriously, then we are very likely to see multiple lockdowns in towns and cities.
I am sure we all agree that our tests cannot come soon enough.
No he continues to hold and grow his position!
I found Avacta via a recommendation from a very good friend. My timing arriving was at the early part of April as ‘Themuir’ will remember. I bought in at 38p with a significant buy and then really built my position in the 70p range.
My reason was the targeted chemotherapy treatment, as my wife had a torrid time last year as many who follow my posting history will well know. I held a short term holding in NYCT from £1.10 adding to £2.20 and sold almost my entire holding at £4.80.
I do actually hold a few still in NYCT. But it is a token as I still see the amazing job they have done. My holding here will be a long term one, unless there is a buyout!
On this question, I can tell you all that medical waste is incinerated to ensure that there is not risk of infection carryover and the burning plastic content is used to create heat energy for power creation at various sites in the UK.
Recycling of potentially Covid19 contaminated plastic is not desirable as they plastic would be washed before recycling and that means Covid19 contaminated water!
Hope this explains how medical waste is treated.
It seems progress is already underway with a therapeutic!
Today announcement is surely another major step forward. Developing this partnership with a relatively small pharmaceutical company like Daewoong, gives both companies a first move advantage. They build and develop the therapy out of the main giants and build a product which could be highly valuable without the cross overs found in other large Pharmaceutical giants. With this opportunity they can feel-something truly live changing and present it to the world hopefully within a patent which will make it very valuable indeed. South Korea will have exposure to potentially different mutations of the virus to the one in Europe and the combinations could prove invaluable.
Dr. Alastair Smith, Chief Executive of Avacta Group commented:
“I am very pleased to have extended our collaboration and license agreement with Daewoong Pharmaceutical to include the SARS-COV-2 neutralising Affimer molecules for the treatment of COVID-19 and to create the potential to respond very rapidly in future to global virus threats.
AffyXell will address the need over the coming years for advanced stem cell therapies to treat lung damage caused by cytokine release syndrome suffered by COVID-19 patients and, at the same time, help prevent disease progression in these patients through the action of a neutralising Affimer therapy.
More broadly, one of the key areas of unmet clinical need that AffyXell can address with its next-generation mesenchymal stem cell therapies is acute pulmonary diseases such as COPD and acute respiratory distress syndrome. We, and our partners in South Korea, are very excited by the potential to develop life improving treatments for patients with these serious respiratory diseases as well as COVID-19.
I look forward to further updating the market on progress in our ground-breaking programmes with AffyXell in due course, and on progress with our COVID-19 diagnostics programmes shortly.”
Seng-ho Jeon, CEO of Daewoong Pharmaceutical and AffyXell Therapeutics, commented:
“It is very encouraging that AffyXell now has the opportunity to expand the application of its next-generation stem cell platform technology to target viruses. The SARS-COV-2 neutralising Affimer to be developed in combination with AffyXell’s cell and gene technology is expected to be an innovative solution for COVID-19 patients suffering cytokine release syndrome.
Daewoong has been also conducting several research programs and clinical trial for COVID-19. As the COVID-19 crisis has caused great difficulties worldwide, we will continue to focus our efforts to develop a novel therapeutic agent for COVID-19.”
I think this will just add a lot more weight to our future and this partnership may prove to be something very good indeed. The jigsaw pieces are coming together beautifully.
So they want to charge £150 per test! Ouch.
So if mass testing is provided by a POC LFT which costs around £10 on departures and £10 on arrivals and keeps the airport open and the world safe then £20 is very cost effective.
If the airports charge £150 per test, then people will just not fly. Imagine added £300 per person to your flight cost!
The airports need the right product at the right cost and they need speed. Queuing at airports are yet another social distancing concern. They need the right test and I am sure Avacta will soon be supplying one!
I am sorry to say this, but I really don’t expect our BAMS or POC test to be anything but a complete success. The only thing that could stop us is a meteorite hitting the earth! I am not aware of one coming yet.
Not sure if this will help anyone who has fears of everything they invest in failing! But, all signs are super positive!
It is interesting how the ebb and flow of the market makers has changed in the last few days. The normal substantial drop has reduced. As normal the MM make it almost impossible now to sell any stock in the immediate moments after opening - totally many were locked out of selling for 15 to 30 minutes by which time the sell had dropped from 148 to 145. However, very quickly the price rose back up and then stayed strong in the 148/150 range for the rest of the day, with what appears strong buying into the end of the day.
Why highlight this now? Well the sentiment has changed, this has gone from a standard pattern to the point where it is showing a strong sign it is going to rise and the market markers now that time is running out before a very significant RNS which will see a big jump not only in the SP but in the market being that this is a company which is not just a strong buy for a PI, but a strong buy for much larger investors. The confirmation of our expectations here are going to drive the price up very quickly. The situation is there are many Covid19 tests on the market but none are able to give what is really needed to make it simple, no swab, no pain, no error and low cost, any time and place any where!
Avacta Share holders here know the situation inside out, and we are pretty clear that the market is going to grow from 500,000 test per day to 20 million tests per day being needed very quickly and the total market is way higher than that. The revenue for this test is truly going to be huge providing everything is right and given the picture presented by the company we have no reason not to expect top S&S results. As I have suggested previously what made the rabbit out of the hat is the point that the result maybe much faster than the 10 minutes initially suggested. If that is the case, then Avacta in reality have nobody close in the race for the gold standard Covid19 Test on the planet!
With this in mind and the multiple other revenue streams coming through to Avacta in the months ahead, with the current travel situation as well as the growth of the virus and the shots across the planet of an acceleration of the virus spread then our product as well as the potential of the virus neutralising project is going to be super valuable.
The time is coming soon and I don't now when but we are going to have one heck of an RNS and our market cap is going to jump to a level we are all going to be surprised by. I think many are know expecting a very strong growth in the next 3 months.
Rightly so! I have no intention of selling any shares here for many months to come!
Have a great evening all!